Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options
Serious bacterial infections among major causes of disability and death for people in healthcare settings.  

Collaboration comes at critical time with studies showing bacterial infections present in half of deceased COVID-19 patients.   

See more here